BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
2157 Total Holdings:
As of 3/31/25
All Holdings:
1 -
15 of
2157
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 34,938,944 | $3,493,894,376.00 | 3.19% |
| Broadcom, Inc. | Equity | 20,499,024 | $3,432,151,588.00 | 3.14% |
| Philip Morris International, Inc. | Equity | 20,603,673 | $3,270,421,015.00 | 2.99% |
| Capital Group Central Corporate Bond Fund | Investment Fund | 310,378,249 | $2,604,073,509.00 | 2.38% |
| AbbVie, Inc. | Equity | 10,840,883 | $2,271,381,806.00 | 2.08% |
| RTX Corp. | Equity | 16,411,451 | $2,173,860,799.00 | 1.99% |
| VICI Properties, Inc. REIT | Equity | 51,846,171 | $1,691,222,098.00 | 1.55% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 59,422,820 | $1,656,577,877.00 | 1.51% |
| Abbott Laboratories | Equity | 11,883,696 | $1,576,372,274.00 | 1.44% |
| JPMorgan Chase & Co. | Equity | 6,337,373 | $1,554,557,597.00 | 1.42% |
| Microsoft Corp. | Equity | 4,043,646 | $1,517,944,272.00 | 1.39% |
| British American Tobacco PLC | Equity | 34,328,019 | $1,415,246,923.00 | 1.29% |
| Gilead Sciences, Inc. | Equity | 12,091,118 | $1,354,809,772.00 | 1.24% |
| Exxon Mobil Corp. | Equity | 10,340,542 | $1,229,800,660.00 | 1.12% |
| Amgen, Inc. | Equity | 3,509,771 | $1,093,469,155.00 | 1% |
All Holdings:
1 -
15 of
2157